Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LA HNSCC”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableLooking for participantsNCT07133958
What this trial is testing

A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)
Zhujiang Hospital 35
Not applicableActive Not RecruitingNCT04599309
What this trial is testing

Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
CancerHead and Neck Squamous Cell CarcinomaHead and Neck Cancer
University Health Network, Toronto 35
Very early researchNot Yet RecruitingNCT07168785
What this trial is testing

[18F]-AraG PET Imaging in LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Locally Advanced Head and Neck Squamous Cell Carcinoma
Indiana University 5
Large-scale testing (Phase 3)Looking for participantsNCT06102395
What this trial is testing

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant TherapyPembrolizumab
Beijing Tongren Hospital 272
Not applicableNot Yet RecruitingNCT06722495
What this trial is testing

Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study

Who this might be right for
SBRTNeoadjuvant ImmunochemotherapyLA HNSCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 20
Testing effectiveness (Phase 2)UnknownNCT05202275
What this trial is testing

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Who this might be right for
NauseaVomitingHead and Neck Squamous Cell Carcinoma+1 more
Chinese Academy of Medical Sciences 43
Testing effectiveness (Phase 2)UnknownNCT02753140
What this trial is testing

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 60
Not applicableStudy completedNCT03663985
What this trial is testing

FALCOn (Facteur AnthropoLogique Cancer Orl)

Who this might be right for
Head and Neck CancerHead and Neck Carcinoma
Institut Claudius Regaud 206
Large-scale testing (Phase 3)Looking for participantsNCT04892173
What this trial is testing

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaAged
Johnson & Johnson Enterprise Innovation Inc. 500
Testing effectiveness (Phase 2)Looking for participantsNCT06494943
What this trial is testing

Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Fudan University 27
Testing effectiveness (Phase 2)Looking for participantsNCT06752798
What this trial is testing

Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC

Who this might be right for
Head and Neck Cancer Squamous Cell Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05213884
What this trial is testing

The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Chongqing University Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172256
What this trial is testing

CUE-101with Pembrolizumab for LA-HPV+HNSCCs

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaNew Diagnosis Tumor+1 more
Yale University 30
Not applicableActive Not RecruitingNCT03838601
What this trial is testing

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Ended earlyNCT01216020
What this trial is testing

Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsLaryngeal NeoplasmsMouth Neoplasms+1 more
Azienda USL 4 Prato 70
Large-scale testing (Phase 3)Looking for participantsNCT07333274
What this trial is testing

Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck Squamous Cell CarcinomaHead & Neck Cancer
Shandong Cancer Hospital and Institute 335
Testing effectiveness (Phase 2)UnknownNCT05351762
What this trial is testing

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Xijing Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT06978829
What this trial is testing

Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC

Who this might be right for
LA HNSCC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 42
Large-scale testing (Phase 3)Ended earlyNCT05386550
What this trial is testing

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Who this might be right for
Head and Neck Cancer
EMD Serono Research & Development Institute, Inc. 166
Large-scale testing (Phase 3)Not Yet RecruitingNCT07371897
What this trial is testing

Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCC
Sun Yat-sen University 154
Load More Results